Web Stats Provided By Google Analytics

Tuesday, July 9, 2013

FDA Grants TNI BioTech, Inc. an End of Phase II Meeting on August 20, ...

... designed to harness the power of the immune system to improve the treatment of cancer, chronic infections such as HIV/AIDS, autoimmune diseases and other types of inflammatory bowel disease, such as Crohn's disease, and multiple sclerosis. TNI ...

http://www.accesswire.com/viewarticle.aspx?id=405704

No comments:

Post a Comment